Gestational Diabetes Mellitus studies

The prevalence of gestational diabetes mellitus is influenced by the race or ethnicity, age, and obesity among women in the delivery population as well as the criteria used to make the diagnosis. Our researchers study the causes, genetics, treatment, and outcomes of women with gestational diabetes and their children.

Effects of air pollution and gestational diabetes on autism

The proposal will gather preliminary biomarker data in newborns in response to air pollution and gestational diabetes exposure in-utero

Principal Investigator:

Anny Hui Xiang, PhD, MS

Funding Source:

Nat'l Inst of Environ Health Sciences

Funding Years:

2017

The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Follow-up Study

The HAPO Follow-up Study will recruit from the cohort of women and their offspring who participated in the original HAPO Study to test the hypothesis that hyperglycemia in pregnancy, less severe than overt diabetes, is independently associated with increased risk of adverse childhood and maternal outcomes 8-12 years later. The general aim of the study is to obtain measures of adiposity, glucose, insulin sensitivity and secretion, lipids, inflammation and blood pressure in 7,000 HAPO mother-offspring (aged 8-12) pairs of multiple ethnic/race groups from ten of the original HAPO field centers. (RO1DK061628)

Site Principal Investigator:

Jean M. Lawrence, ScD, MPH, MSSA

Funding Source:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Funding Years:

2012 - 2017

The Virtual Visit for Women with Gestational Diabetes Mellitus (GDM)

This pilot study will address two specific aims: (1) to assess the acceptability of telemedicine technology to conduct virtual office visits alternating with regular office- based prenatal visits for women with GDM from the viewpoint of women with GDM and their health care providers using qualitative research methods, and (2) to assess the feasibility of this telemedicine-based intervention (Virtual Office Visit) for women with GDM. This information was be used to support a larger proposal to obtain funding to conduct a clinical trial to test the proposed intervention after it is refined based on input from patients and health care providers.

Principal Investigator:

David A. Sacks, MD

Funding Source:

Kaiser Permanente, Southern California

Funding Years:

2014